Clinical Trial Update: Systems Biological Analysis of Immune Responses to RSV Vaccine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is studying systems biological analyses of immune responses to an RSV vaccine, with the study currently ACTIVE_NOT_RECRUITING at Emory …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSV vaccine (respiratory syncytial virus vaccine)

Snippet

Sponsor: Emory University | Conditions: Respiratory Syncytial Virus (RSV) | Phase 4 | Status: ACTIVE_NOT_RECRUITING